• Citer

Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly patients with advanced pancreatic cancer.

par Marechal, Raphaël ;Demols, Anne ;Gay, France ;De Maertelaer, Viviane ;Arvanitakis, Marianna ;Hendlisz, Alain ;Van Laethem, Jean-Luc
Référence Pancreas, 36, 3, page (e16-e21)
Publication Publié, 2008-04

Article révisé par les pairs

• Détails
• Contenu

Résumé :

Gemcitabine is the backbone therapy of patients with advanced pancreatic cancer. Its tolerability and efficacy remain poorly studied in elderly.